Neeraj Kumar, Amardeep Awasthi, Anchala Kumari, Damini Sood, Pallavi Jain, Taru Singh, Neera Sharma, Abhinav Grover, Ramesh Chandra. J Biomol Struct Dyn 2022
Times Cited: 19
Times Cited: 19
Times Cited
Times Co-cited
Similarity
Molecular Binding Mechanism and Pharmacology Comparative Analysis of Noscapine for Repurposing against SARS-CoV-2 Protease.
Neeraj Kumar, Damini Sood, Peter J van der Spek, Hari S Sharma, Ramesh Chandra. J Proteome Res 2020
Neeraj Kumar, Damini Sood, Peter J van der Spek, Hari S Sharma, Ramesh Chandra. J Proteome Res 2020
36
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors.
Zhenming Jin, Xiaoyu Du, Yechun Xu, Yongqiang Deng, Meiqin Liu, Yao Zhao, Bing Zhang, Xiaofeng Li, Leike Zhang, Chao Peng,[...]. Nature 2020
Zhenming Jin, Xiaoyu Du, Yechun Xu, Yongqiang Deng, Meiqin Liu, Yao Zhao, Bing Zhang, Xiaofeng Li, Leike Zhang, Chao Peng,[...]. Nature 2020
36
Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors.
Linlin Zhang, Daizong Lin, Xinyuanyuan Sun, Ute Curth, Christian Drosten, Lucie Sauerhering, Stephan Becker, Katharina Rox, Rolf Hilgenfeld. Science 2020
Linlin Zhang, Daizong Lin, Xinyuanyuan Sun, Ute Curth, Christian Drosten, Lucie Sauerhering, Stephan Becker, Katharina Rox, Rolf Hilgenfeld. Science 2020
31
Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease.
Wenhao Dai, Bing Zhang, Xia-Ming Jiang, Haixia Su, Jian Li, Yao Zhao, Xiong Xie, Zhenming Jin, Jingjing Peng, Fengjiang Liu,[...]. Science 2020
Wenhao Dai, Bing Zhang, Xia-Ming Jiang, Haixia Su, Jian Li, Yao Zhao, Xiong Xie, Zhenming Jin, Jingjing Peng, Fengjiang Liu,[...]. Science 2020
31
The SARS-CoV-2 main protease as drug target.
Sven Ullrich, Christoph Nitsche. Bioorg Med Chem Lett 2020
Sven Ullrich, Christoph Nitsche. Bioorg Med Chem Lett 2020
26
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.
Philippe Gautret, Jean-Christophe Lagier, Philippe Parola, Van Thuan Hoang, Line Meddeb, Morgane Mailhe, Barbara Doudier, Johan Courjon, Valérie Giordanengo, Vera Esteves Vieira,[...]. Int J Antimicrob Agents 2020
Philippe Gautret, Jean-Christophe Lagier, Philippe Parola, Van Thuan Hoang, Line Meddeb, Morgane Mailhe, Barbara Doudier, Johan Courjon, Valérie Giordanengo, Vera Esteves Vieira,[...]. Int J Antimicrob Agents 2020
21
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro.
Manli Wang, Ruiyuan Cao, Leike Zhang, Xinglou Yang, Jia Liu, Mingyue Xu, Zhengli Shi, Zhihong Hu, Wu Zhong, Gengfu Xiao. Cell Res 2020
Manli Wang, Ruiyuan Cao, Leike Zhang, Xinglou Yang, Jia Liu, Mingyue Xu, Zhengli Shi, Zhihong Hu, Wu Zhong, Gengfu Xiao. Cell Res 2020
21
Identification of potential Mpro inhibitors for the treatment of COVID-19 by using systematic virtual screening approach.
Ashish M Kanhed, Dushyant V Patel, Divya M Teli, Nirav R Patel, Mahesh T Chhabria, Mange Ram Yadav. Mol Divers 2021
Ashish M Kanhed, Dushyant V Patel, Divya M Teli, Nirav R Patel, Mahesh T Chhabria, Mange Ram Yadav. Mol Divers 2021
21
In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.
Yogesh Kumar, Harvijay Singh, Chirag N Patel. J Infect Public Health 2020
Yogesh Kumar, Harvijay Singh, Chirag N Patel. J Infect Public Health 2020
21
Coronaviruses: an overview of their replication and pathogenesis.
Anthony R Fehr, Stanley Perlman. Methods Mol Biol 2015
Anthony R Fehr, Stanley Perlman. Methods Mol Biol 2015
21
Ligand and structure-based virtual screening applied to the SARS-CoV-2 main protease: an in silico repurposing study.
Witor Ribeiro Ferraz, Renan Augusto Gomes, Andre Luis S Novaes, Gustavo Henrique Goulart Trossini. Future Med Chem 2020
Witor Ribeiro Ferraz, Renan Augusto Gomes, Andre Luis S Novaes, Gustavo Henrique Goulart Trossini. Future Med Chem 2020
21
SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules.
Antoine Daina, Olivier Michielin, Vincent Zoete. Sci Rep 2017
Antoine Daina, Olivier Michielin, Vincent Zoete. Sci Rep 2017
21
AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading.
Oleg Trott, Arthur J Olson. J Comput Chem 2010
Oleg Trott, Arthur J Olson. J Comput Chem 2010
21
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.
David E Gordon, Gwendolyn M Jang, Mehdi Bouhaddou, Jiewei Xu, Kirsten Obernier, Kris M White, Matthew J O'Meara, Veronica V Rezelj, Jeffrey Z Guo, Danielle L Swaney,[...]. Nature 2020
David E Gordon, Gwendolyn M Jang, Mehdi Bouhaddou, Jiewei Xu, Kirsten Obernier, Kris M White, Matthew J O'Meara, Veronica V Rezelj, Jeffrey Z Guo, Danielle L Swaney,[...]. Nature 2020
15
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19.
Bin Cao, Yeming Wang, Danning Wen, Wen Liu, Jingli Wang, Guohui Fan, Lianguo Ruan, Bin Song, Yanping Cai, Ming Wei,[...]. N Engl J Med 2020
Bin Cao, Yeming Wang, Danning Wen, Wen Liu, Jingli Wang, Guohui Fan, Lianguo Ruan, Bin Song, Yanping Cai, Ming Wei,[...]. N Engl J Med 2020
15
Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods.
Canrong Wu, Yang Liu, Yueying Yang, Peng Zhang, Wu Zhong, Yali Wang, Qiqi Wang, Yang Xu, Mingxue Li, Xingzhou Li,[...]. Acta Pharm Sin B 2020
Canrong Wu, Yang Liu, Yueying Yang, Peng Zhang, Wu Zhong, Yali Wang, Qiqi Wang, Yang Xu, Mingxue Li, Xingzhou Li,[...]. Acta Pharm Sin B 2020
15
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding.
Roujian Lu, Xiang Zhao, Juan Li, Peihua Niu, Bo Yang, Honglong Wu, Wenling Wang, Hao Song, Baoying Huang, Na Zhu,[...]. Lancet 2020
Roujian Lu, Xiang Zhao, Juan Li, Peihua Niu, Bo Yang, Honglong Wu, Wenling Wang, Hao Song, Baoying Huang, Na Zhu,[...]. Lancet 2020
15
Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study.
Qingxian Cai, Minghui Yang, Dongjing Liu, Jun Chen, Dan Shu, Junxia Xia, Xuejiao Liao, Yuanbo Gu, Qiue Cai, Yang Yang,[...]. Engineering (Beijing) 2020
Qingxian Cai, Minghui Yang, Dongjing Liu, Jun Chen, Dan Shu, Junxia Xia, Xuejiao Liao, Yuanbo Gu, Qiue Cai, Yang Yang,[...]. Engineering (Beijing) 2020
15
Emerging coronaviruses: Genome structure, replication, and pathogenesis.
Yu Chen, Qianyun Liu, Deyin Guo. J Med Virol 2020
Yu Chen, Qianyun Liu, Deyin Guo. J Med Virol 2020
15
The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2.
. Nat Microbiol 2020
. Nat Microbiol 2020
15
Structure-based drug designing for potential antiviral activity of selected natural products from Ayurveda against SARS-CoV-2 spike glycoprotein and its cellular receptor.
Vimal K Maurya, Swatantra Kumar, Anil K Prasad, Madan L B Bhatt, Shailendra K Saxena. Virusdisease 2020
Vimal K Maurya, Swatantra Kumar, Anil K Prasad, Madan L B Bhatt, Shailendra K Saxena. Virusdisease 2020
15
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.
Chaolin Huang, Yeming Wang, Xingwang Li, Lili Ren, Jianping Zhao, Yi Hu, Li Zhang, Guohui Fan, Jiuyang Xu, Xiaoying Gu,[...]. Lancet 2020
Chaolin Huang, Yeming Wang, Xingwang Li, Lili Ren, Jianping Zhao, Yi Hu, Li Zhang, Guohui Fan, Jiuyang Xu, Xiaoying Gu,[...]. Lancet 2020
15
Putative Inhibitors of SARS-CoV-2 Main Protease from A Library of Marine Natural Products: A Virtual Screening and Molecular Modeling Study.
Davide Gentile, Vincenzo Patamia, Angela Scala, Maria Teresa Sciortino, Anna Piperno, Antonio Rescifina. Mar Drugs 2020
Davide Gentile, Vincenzo Patamia, Angela Scala, Maria Teresa Sciortino, Anna Piperno, Antonio Rescifina. Mar Drugs 2020
15
The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor.
Haitao Yang, Maojun Yang, Yi Ding, Yiwei Liu, Zhiyong Lou, Zhe Zhou, Lei Sun, Lijuan Mo, Sheng Ye, Hai Pang,[...]. Proc Natl Acad Sci U S A 2003
Haitao Yang, Maojun Yang, Yi Ding, Yiwei Liu, Zhiyong Lou, Zhe Zhou, Lei Sun, Lijuan Mo, Sheng Ye, Hai Pang,[...]. Proc Natl Acad Sci U S A 2003
15
Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs.
Kanchan Anand, John Ziebuhr, Parvesh Wadhwani, Jeroen R Mesters, Rolf Hilgenfeld. Science 2003
Kanchan Anand, John Ziebuhr, Parvesh Wadhwani, Jeroen R Mesters, Rolf Hilgenfeld. Science 2003
15
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.
Nanshan Chen, Min Zhou, Xuan Dong, Jieming Qu, Fengyun Gong, Yang Han, Yang Qiu, Jingli Wang, Ying Liu, Yuan Wei,[...]. Lancet 2020
Nanshan Chen, Min Zhou, Xuan Dong, Jieming Qu, Fengyun Gong, Yang Han, Yang Qiu, Jingli Wang, Ying Liu, Yuan Wei,[...]. Lancet 2020
15
Structures of two coronavirus main proteases: implications for substrate binding and antiviral drug design.
Xiaoyu Xue, Hongwei Yu, Haitao Yang, Fei Xue, Zhixin Wu, Wei Shen, Jun Li, Zhe Zhou, Yi Ding, Qi Zhao,[...]. J Virol 2008
Xiaoyu Xue, Hongwei Yu, Haitao Yang, Fei Xue, Zhixin Wu, Wei Shen, Jun Li, Zhe Zhou, Yi Ding, Qi Zhao,[...]. J Virol 2008
15
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor.
Jun Lan, Jiwan Ge, Jinfang Yu, Sisi Shan, Huan Zhou, Shilong Fan, Qi Zhang, Xuanling Shi, Qisheng Wang, Linqi Zhang,[...]. Nature 2020
Jun Lan, Jiwan Ge, Jinfang Yu, Sisi Shan, Huan Zhou, Shilong Fan, Qi Zhang, Xuanling Shi, Qisheng Wang, Linqi Zhang,[...]. Nature 2020
15
Vaccine Formulation and Optimization for Human Herpes Virus-5 through an Immunoinformatics Framework.
Neeraj Kumar, Damini Sood, Ramesh Chandra. ACS Pharmacol Transl Sci 2020
Neeraj Kumar, Damini Sood, Ramesh Chandra. ACS Pharmacol Transl Sci 2020
60
Cytotoxic T-lymphocyte elicited vaccine against SARS-CoV-2 employing immunoinformatics framework.
Neeraj Kumar, Nikita Admane, Anchala Kumari, Damini Sood, Sonam Grover, Vijay Kumar Prajapati, Ramesh Chandra, Abhinav Grover. Sci Rep 2021
Neeraj Kumar, Nikita Admane, Anchala Kumari, Damini Sood, Sonam Grover, Vijay Kumar Prajapati, Ramesh Chandra, Abhinav Grover. Sci Rep 2021
37
Design and optimization of a subunit vaccine targeting COVID-19 molecular shreds using an immunoinformatics framework.
Neeraj Kumar, Damini Sood, Ramesh Chandra. RSC Adv 2020
Neeraj Kumar, Damini Sood, Ramesh Chandra. RSC Adv 2020
30
An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study.
Sourav Das, Sharat Sarmah, Sona Lyndem, Atanu Singha Roy. J Biomol Struct Dyn 2021
Sourav Das, Sharat Sarmah, Sona Lyndem, Atanu Singha Roy. J Biomol Struct Dyn 2021
15
Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach.
Salman Ali Khan, Komal Zia, Sajda Ashraf, Reaz Uddin, Zaheer Ul-Haq. J Biomol Struct Dyn 2021
Salman Ali Khan, Komal Zia, Sajda Ashraf, Reaz Uddin, Zaheer Ul-Haq. J Biomol Struct Dyn 2021
15
Pharmacoinformatics and molecular dynamics simulation studies reveal potential covalent and FDA-approved inhibitors of SARS-CoV-2 main protease 3CLpro.
Mubarak A Alamri, Muhammad Tahir Ul Qamar, Muhammad Usman Mirza, Rajendra Bhadane, Safar M Alqahtani, Iqra Muneer, Matheus Froeyen, Outi M H Salo-Ahen. J Biomol Struct Dyn 2021
Mubarak A Alamri, Muhammad Tahir Ul Qamar, Muhammad Usman Mirza, Rajendra Bhadane, Safar M Alqahtani, Iqra Muneer, Matheus Froeyen, Outi M H Salo-Ahen. J Biomol Struct Dyn 2021
15
Investigation of Some Antiviral N-Heterocycles as COVID 19 Drug: Molecular Docking and DFT Calculations.
Mohamed Hagar, Hoda A Ahmed, Ghadah Aljohani, Omaima A Alhaddad. Int J Mol Sci 2020
Mohamed Hagar, Hoda A Ahmed, Ghadah Aljohani, Omaima A Alhaddad. Int J Mol Sci 2020
15
Understanding the binding affinity of noscapines with protease of SARS-CoV-2 for COVID-19 using MD simulations at different temperatures.
Durgesh Kumar, Kamlesh Kumari, Abhilash Jayaraj, Vinod Kumar, Ramappa Venkatesh Kumar, Sujata K Dass, Ramesh Chandra, Prashant Singh. J Biomol Struct Dyn 2021
Durgesh Kumar, Kamlesh Kumari, Abhilash Jayaraj, Vinod Kumar, Ramappa Venkatesh Kumar, Sujata K Dass, Ramesh Chandra, Prashant Singh. J Biomol Struct Dyn 2021
10
Chloroquine is a potent inhibitor of SARS coronavirus infection and spread.
Martin J Vincent, Eric Bergeron, Suzanne Benjannet, Bobbie R Erickson, Pierre E Rollin, Thomas G Ksiazek, Nabil G Seidah, Stuart T Nichol. Virol J 2005
Martin J Vincent, Eric Bergeron, Suzanne Benjannet, Bobbie R Erickson, Pierre E Rollin, Thomas G Ksiazek, Nabil G Seidah, Stuart T Nichol. Virol J 2005
10
Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.
James M Sanders, Marguerite L Monogue, Tomasz Z Jodlowski, James B Cutrell. JAMA 2020
James M Sanders, Marguerite L Monogue, Tomasz Z Jodlowski, James B Cutrell. JAMA 2020
10
Simultaneous treatment of human bronchial epithelial cells with serine and cysteine protease inhibitors prevents severe acute respiratory syndrome coronavirus entry.
Miyuki Kawase, Kazuya Shirato, Lia van der Hoek, Fumihiro Taguchi, Shutoku Matsuyama. J Virol 2012
Miyuki Kawase, Kazuya Shirato, Lia van der Hoek, Fumihiro Taguchi, Shutoku Matsuyama. J Virol 2012
10
The proximal origin of SARS-CoV-2.
Kristian G Andersen, Andrew Rambaut, W Ian Lipkin, Edward C Holmes, Robert F Garry. Nat Med 2020
Kristian G Andersen, Andrew Rambaut, W Ian Lipkin, Edward C Holmes, Robert F Garry. Nat Med 2020
10
Tocilizumab: a review of its use in the management of rheumatoid arthritis.
Vicki Oldfield, Sohita Dhillon, Greg L Plosker. Drugs 2009
Vicki Oldfield, Sohita Dhillon, Greg L Plosker. Drugs 2009
10
Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses.
Michael Letko, Andrea Marzi, Vincent Munster. Nat Microbiol 2020
Michael Letko, Andrea Marzi, Vincent Munster. Nat Microbiol 2020
10
Computational guided drug repurposing for targeting 2'-O-ribose methyltransferase of SARS-CoV-2.
Kedar Sharma, Sudhir Morla, Arun Goyal, Sachin Kumar. Life Sci 2020
Kedar Sharma, Sudhir Morla, Arun Goyal, Sachin Kumar. Life Sci 2020
12
Favipiravir: Pharmacokinetics and Concerns About Clinical Trials for 2019-nCoV Infection.
Yin-Xiao Du, Xiao-Ping Chen. Clin Pharmacol Ther 2020
Yin-Xiao Du, Xiao-Ping Chen. Clin Pharmacol Ther 2020
10
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
Markus Hoffmann, Hannah Kleine-Weber, Simon Schroeder, Nadine Krüger, Tanja Herrler, Sandra Erichsen, Tobias S Schiergens, Georg Herrler, Nai-Huei Wu, Andreas Nitsche,[...]. Cell 2020
Markus Hoffmann, Hannah Kleine-Weber, Simon Schroeder, Nadine Krüger, Tanja Herrler, Sandra Erichsen, Tobias S Schiergens, Georg Herrler, Nai-Huei Wu, Andreas Nitsche,[...]. Cell 2020
10
Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments.
G Madhavi Sastry, Matvey Adzhigirey, Tyler Day, Ramakrishna Annabhimoju, Woody Sherman. J Comput Aided Mol Des 2013
G Madhavi Sastry, Matvey Adzhigirey, Tyler Day, Ramakrishna Annabhimoju, Woody Sherman. J Comput Aided Mol Des 2013
10
Inhibitory activity of hydroxychloroquine on COVID-19 main protease: An insight from MD-simulation studies.
Nabajyoti Baildya, Narendra Nath Ghosh, Asoke P Chattopadhyay. J Mol Struct 2020
Nabajyoti Baildya, Narendra Nath Ghosh, Asoke P Chattopadhyay. J Mol Struct 2020
10
Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur.
Zhenming Jin, Yao Zhao, Yuan Sun, Bing Zhang, Haofeng Wang, Yan Wu, Yan Zhu, Chen Zhu, Tianyu Hu, Xiaoyu Du,[...]. Nat Struct Mol Biol 2020
Zhenming Jin, Yao Zhao, Yuan Sun, Bing Zhang, Haofeng Wang, Yan Wu, Yan Zhu, Chen Zhu, Tianyu Hu, Xiaoyu Du,[...]. Nat Struct Mol Biol 2020
10
Revealing the molecular mechanisms of proteolysis of SARS-CoV-2 Mpro by QM/MM computational methods.
Katarzyna Świderek, Vicent Moliner. Chem Sci 2020
Katarzyna Świderek, Vicent Moliner. Chem Sci 2020
10
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.